Cargando…
Changes in management of idiopathic pulmonary fibrosis: impact on disease severity and mortality
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a serious interstitial lung disease (ILD) with a median survival of 3-5 years. The aim of the present study was to evaluate disease severity and survival in patients diagnosed with IPF in the era of antifibrotic therapies compared with an earlier IP...
Autores principales: | Hyldgaard, Charlotte, Møller, Janne, Bendstrup, Elisabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480407/ https://www.ncbi.nlm.nih.gov/pubmed/32944203 http://dx.doi.org/10.1080/20018525.2020.1807682 |
Ejemplares similares
-
Economic consequences of idiopathic pulmonary fibrosis in Denmark
por: Hilberg, Ole, et al.
Publicado: (2018) -
Organisation of diagnosis and treatment of idiopathic pulmonary fibrosis and other interstitial lung diseases in the Nordic countries
por: Bendstrup, Elisabeth, et al.
Publicado: (2015) -
Hypersensitivity pneumonitis among wind musicians – an overlooked disease?
por: Møller, Janne, et al.
Publicado: (2017) -
Interstitial Lung Disease in Rheumatoid Arthritis Remains a Challenge for Clinicians
por: Bendstrup, Elisabeth, et al.
Publicado: (2019) -
Eosinophil alveolitis in two patients with idiopathic pulmonary fibrosis
por: Brix, Ninna, et al.
Publicado: (2016)